Alkylating agents for treatment of cellular proliferation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/195 (2006.01) A61K 31/00 (2006.01) A61K 31/165 (2006.01) A61K 31/175 (2006.01) A61K 31/19 (2006.01) A61K 31/255 (2006.01) A61K 31/275 (2006.01) A61K 31/335 (2006.01) A61K 31/57 (2006.01) A61K 45/06 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2362883

A method of inhibiting cellular proliferation associated with a hyperproliferative condition, such as restenosis, is described. The method includes administering an alkylating agent. A stent for local administration of the alkylating agent is also described.

La présente invention concerne une méthode d'inhibition de prolifération cellulaire associée à une condition d'hyperprolifération telle que la resténose. Cette méthode consiste à administrer un agent d'alkylation. L'invention concerne aussi un extenseur destiné à administrer l'agent localement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Alkylating agents for treatment of cellular proliferation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alkylating agents for treatment of cellular proliferation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylating agents for treatment of cellular proliferation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1799518

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.